Federal government undermines COVID-19 vaccine development
Canada’s amended Patent Act weakens protections for intellectual property in the life sciences just when rights are vital for mobilizing a rapid response
Read MorePosted by Kristina Acri | Aug 7, 2020
Canada’s amended Patent Act weakens protections for intellectual property in the life sciences just when rights are vital for mobilizing a rapid response
Read MorePosted by Kristina Acri | Jan 7, 2020
The new trade agreement represents progress for international trade, but crucially, it weakens protections for the biopharma industry
Read MorePosted by Kristina Acri | Sep 24, 2019
Canada must cautiously approach any policy change that puts patients, innovation and innovative industries at risk
Read MorePosted by Bacchus Barua | Sep 8, 2019
Both countries partner with the private sector and expect patients to share the cost of treatment
Read MorePosted by Kristina Acri | Mar 14, 2019
Will likely result in reduced access to new drugs, and delay research and development
Read More